Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial

Annals of Internal Medicine

Volumn 125, Issue 6, 1996, Pages 442-447

  Van Den Hazel, Sven J ^a   Speelman, Peter ^a   Dankert, Jacob ^a   Huibregtse, Kees ^a   Tytgat, Guido N J ^a   Van Leeuwen, Dirk J ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b University of Alabama at Birmingham School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; PIPERACILLIN; PLACEBO;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHOLANGITIS; CHOLELITHIASIS; CHOLESTASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; CHOLELITHIASIS; CHOLESTASIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLINS; PIPERACILLIN; PLACEBOS;

EID: 0030587259     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-6-199609150-00002     Document Type: Article

References (19)

1. Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology. 1976;70:314-20.
2. Huibregtse K. Endoscopic Biliary and Pancreatic Drainage. New York: Georg Thieme Verlag; 1988:121-3.
3. Devière J, Motte S, Dumonceau JM, Serruys E, Thys JP, Cremer M. Septicemia after endoscopic retrograde cholangiopancreatography. Endoscopy. 1990;22:72-5.
4. Motte S, Devière J, Dumonceau JM, Serruys E, Thys JP. Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology. 1991;101:1374-81.
5. Alveyn CG, Robertson DA, Wright R, Lowes JA, Tillotson G. Prevention of sepsis following endoscopic retrograde cholangiopancreatography. J Hosp Infect. 1991;19(Suppl C):65-70.
6. Niederau C, Pohlmann U, Lübke H, Thomas L. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc. 1994;40:533-7.
7. Brandes JW, Scheffer B, Lorenz-Meyer H, Körst HA, Littmann KP. ERCP: complications and prophylaxis. A controlled study. Endoscopy. 1981;13:27-30.
8. Sauter G, Grabein B, Huber G, Mannes GA, Ruckdeschel G, Sauerbruch T. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy. 1990;22:164-7.
9. Taylor EW, Poxon V, Alexander-Williams J, Jackson D. Biliary excretion of piperacillin. J Int Med Res. 1983;11:28-31.
10. Chamberland S, L'Ecuyer J, Lessard C, Bernier M, Provencher P, Bergeron MG. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group. Clin Infect Dis. 1992;15:615-8.
11. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383-93.
12. Vaira D, d'Anna L, Ainley C, Dowsett J, Williams S, Baillie J, et al. Endoscopic sphincterotomy in 1000 consecutive patients. Lancet. 1989;2:431-4.
13. Pitt HA, Postier RG, Cameron JL. Biliary bacteria: significance and alterations after antibiotic therapy. Arch Surg. 1982;117:445-9.
14. Maluenda F, Csendes A, Burdiles P, Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology. 1989;36:132-5.
15. Taylor EW, Poxon V, Alexander-Williams J, Jackson D. Biliary excretion of piperacillin. J Int Med Res. 1983;11:28-31.
16. Blenkharn JI, Habib N, Mok D, John L, McPherson GA, Gibson RN, et al. Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice. Antimicrob Agents Chemother. 1985;28:778-80.
17. Keighley MR, Drysdale RB, Quoraishi AH, Burdon DW, Alexander-Williams J. Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum. Gut. 1975;17:495-500.
18. Lobo AJ, Lynch DA, Thornton JR, Hawkey PM, Lintott DJ, Axon AT. High prevalence of coliform bacteria resistant to piperacillin in patients undergoing therapeutic ERCP. Gastroenterology. 1992;102:A320.
19. Byl B, Devière J, Struelens MJ, Roucloux I, De Coninck A, Thys JP, et al. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study. Clin Infect Dis. 1996;20:1236-40.